An essential link for gene therapy
Patient advocacy organizations are critical for advancing gene therapy research and clinical trial success. Throughout our history, we have established significant, meaningful relationships with advocacy groups centered on patients and the urgent need many genetic diseases create.
Advocacy groups are some of our greatest collaborators. Our close associations are key to prioritizing clinical candidates, establishing research protocols, and advancing technology innovation.
Our advocacy partners
We partner with advocacy groups to support research, education and events that benefit patients, advance science and improve outcomes.
- Muscular Dystrophy Association
- Parent Project Muscular Dystrophy
- AMDA – Acid Maltase Deficiency Association
- International Pompe Association
- Speak Foundation
- CureLGMD2i Foundation
- ALS Therapy Development Institute
- Nationwide Children’s Hospital
- North Carolina Biotechnology Center
- North Carolina Board of Science & Technology
The AskBio pipeline
Our pipeline is the direct result of listening to patients, their families, their care teams, and patient advocacy organizations.